Nevele-based Biotope by VIB has secured €5 million in the first close of its second fund, with a target of €9 million over the next 18 months. The Biotope Ventures fund aims to invest €250,000 in up to 30 early-stage biotech startups globally.
- Biotope Ventures, founded by Annick Verween and Jérôme Van Biervliet, is an early-stage investor and accelerator established by VIB. It supports biotech startups through pre-seed funding, access to labs and facilities, and tailored mentorship.
- Twice a year, selected startups participate in a rigorous 3-week program to refine their technology before pitching for a €250,000 investment. Up to three startups then receive hands-on support to de-risk their technology, strengthen IP and regulatory strategies, and prepare for their next funding round.
- Over three years, Biotope’s first fund invested in 16 European startups across food, agriculture, and materials. Four have closed seed rounds, and the portfolio has raised €30 million in follow-on financing, nearly half of which comes from grants, resulting in over 10x capital leverage.
- The new fund aims to support up to 30 early-stage biotech startups worldwide, providing €250,000 each to accelerate innovative solutions for planetary health.
“This first close is an amazing milestone for us. The funding we provide is about more than just runway, it’s about freedom. With €250K cash investment, founders can focus on unlocking the potential of their technology without being distracted by short-term fundraising pressure," claims Annick Verween, Head of biotope.
- The €5 million fund received backing from BNP Paribas Fortis, Agri Investment Fund, SFPIM Relaunch, Anacura, the Flemish Biotechnology Institute, and family offices The Nest and Edaphon.
“We are proud to invest in Biotope Ventures 2 as it offers a rare combination of deep scientific expertise, hands-on entrepreneurship support, and access to a powerful ecosystem of experts, investors, and facilities," Managing Partner at Edaphon, Vincent Vliebergh, commented.
